• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

    2/13/25 4:01:03 PM ET
    $DOCS
    EDP Services
    Technology
    Get the next $DOCS alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 4)


    Doximity, Inc.

    (Name of Issuer)


    CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE

    (Title of Class of Securities)


    26622P107

    (CUSIP Number)


    12/31/2024

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    26622P107


    1Names of Reporting Persons

    Emergence Capital Partners II, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    4,820,546.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    4,820,546.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    4,820,546.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.6 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  1. Represents 4,820,546 shares of Class B Common Stock held directly by Emergence Capital Partners II, L.P. Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer's certificate of incorporation. 2. The percent of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    SCHEDULE 13G

    CUSIP No.
    26622P107


    1Names of Reporting Persons

    Emergence Capital Opportunity I, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    581,250.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    581,250.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    581,250.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.5 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  1. Represents 581,250 shares of Class A Common Stock held directly by Emergence Capital Opportunity I, L.P. 2. The percent of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024.


    SCHEDULE 13G

    CUSIP No.
    26622P107


    1Names of Reporting Persons

    Emergence Equity Partners II, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    4,820,546.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    4,820,546.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    4,820,546.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    3.6 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  1. Represents 4,820,546 shares of Class B Common Stock held directly by Emergence Capital Partners II, L.P. ("ECP II"). Emergence Equity Partners II, L.P. is the sole general partner of ECP II, and may be deemed to beneficially own the shares of stock held directly by ECP II. Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer's certificate of incorporation. 2. The percent of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    SCHEDULE 13G

    CUSIP No.
    26622P107


    1Names of Reporting Persons

    Emergence Equity Partners VI, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    581,250.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    581,250.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    581,250.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0.5 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  1. Represents 581,250 shares of Class A Common Stock held directly by Emergence Capital Opportunity I, L.P. ("ECO I"). Emergence Equity Partners VI, L.P., is the sole general partner of ECO I, and may be deemed to beneficially own the shares of stock held directly by ECO I. 2. The percent of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    SCHEDULE 13G

    CUSIP No.
    26622P107


    1Names of Reporting Persons

    Emergence GP Partners, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    5,401,796.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    5,401,796.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,401,796.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.1 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  1. Represents 4,820,546 shares of Class B Common Stock held directly by ECP II and 581,250 shares of Class A Common Stock held directly by ECO I. Each share of Class A Common Stock is entitled to one vote, and each share of Class B Common Stock is entitled to ten votes. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon certain events specified in the Issuer's certificate of incorporation. 2. The percent of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Doximity, Inc.
    (b)Address of issuer's principal executive offices:

    500 3rd Street, Suite 510, San Francisco, California 94107
    Item 2. 
    (a)Name of person filing:

    (i) Emergence Capital Partners II, L.P., a Delaware limited partnership; (ii) Emergence Capital Opportunity I, L.P., a Delaware limited partnership; (iii) Emergence Equity Partners II, L.P., a Delaware limited partnership; (iv) Emergence Equity Partners VI, L.P., a Delaware limited partnership; and (v) Emergence GP Partners, LLC, a Delaware limited liability company.
    (b)Address or principal business office or, if none, residence:

    The address of the principal business office of each of the reporting persons are 5 Pier, Ste. 102, San Francisco, CA 94111.
    (c)Citizenship:

    See Item 2(a) above.
    (d)Title of class of securities:

    CLASS A COMMON STOCK, $0.001 PAR VALUE PER SHARE
    (e)CUSIP No.:

    26622P107
    Item 4.Ownership
    (a)Amount beneficially owned:

    (i) Emergence Capital Partners II, L.P. ("ECP II") directly owns 4,820,526 shares of Class B Common Stock, which, when such shares are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 3.6% of the outstanding shares of Class A Common Stock. (ii) Emergence Capital Opportunity I, L.P. ("ECO I") directly owns 581,250 shares of Class A Common Stock, which, represents approximately 0.5% of the outstanding shares of Class A Common Stock. (iii) Emergence Equity Partners II, L.P. ("EEP II") is the sole general partner of ECP II, and may be deemed to beneficially own 4,820,546 shares of Class B Common Stock, which, when such shares are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 3.6% of the outstanding shares of Class A Common Stock. (iv) Emergence Equity Partners VI, L.P. ("EEP VI") is the sole general partner of ECO I, and may be deemed to beneficially own 581,250 shares of Class A Common Stock, which, represents approximately 0.5% of the outstanding shares of Class A Common Stock. (v) Emergence GP Partners, LLC ("EGP") is the sole general partner of EEP II and the sole general partner of EEP VI, and may be deemed to beneficially own 4,820,546 shares of Class B Common Stock and 581,250 shares of Class A Common Stock held directly by ECP II and ECO I, respectively, which, when such shares of Class B Common Stock are treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, represents approximately 4.1% of the outstanding shares of Class A Common Stock.
    (b)Percent of class:

    See Item 4(a) above. The percent of class was calculated based on 128,135,991 shares of Class A Common Stock outstanding as of October 31, 2024, as set forth in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 7, 2024. Pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, the Class B Common Stock beneficially owned by the reporting person is treated as converted into Class A Common Stock only for purposes of computing the percentage ownership of the reporting person.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    ECP II: 4,820,546 shares ECO I: 581,250 shares EEP II: 4,820,546 shares EEP VI: 581,250 shares EGP: 5,401,796 shares

     (ii) Shared power to vote or to direct the vote:

    N/A

     (iii) Sole power to dispose or to direct the disposition of:

    ECP II: 4,820,546 shares ECO I: 581,250 shares EEP II: 4,820,546 shares EEP VI: 581,250 shares EGP: 5,401,796 shares

     (iv) Shared power to dispose or to direct the disposition of:

    N/A

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Emergence Capital Partners II, L.P.
     
    Signature:/s/ Julie Bell
    Name/Title:Julie Bell, Attorney-in-Fact
    Date:02/13/2025
     
    Emergence Capital Opportunity I, L.P.
     
    Signature:/s/ Julie Bell
    Name/Title:Julie Bell, Attorney-in-Fact
    Date:02/13/2025
     
    Emergence Equity Partners II, L.P.
     
    Signature:/s/ Julie Bell
    Name/Title:Julie Bell, Attorney-in-Fact
    Date:02/13/2025
     
    Emergence Equity Partners VI, L.P.
     
    Signature:/s/ Julie Bell
    Name/Title:Julie Bell, Attorney-in-Fact
    Date:02/13/2025
     
    Emergence GP Partners, LLC
     
    Signature:/s/ Julie Bell
    Name/Title:Julie Bell, Attorney-in-Fact
    Date:02/13/2025
    Get the next $DOCS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOCS

    DatePrice TargetRatingAnalyst
    2/7/2025$31.00 → $78.00Neutral → Overweight
    Piper Sandler
    2/7/2025$60.00 → $90.00Market Perform → Outperform
    Leerink Partners
    12/20/2024$55.00Equal-Weight
    Stephens
    12/4/2024$55.00Neutral
    Mizuho
    11/15/2024$58.00Neutral
    Goldman
    11/14/2024$33.00 → $53.00Underweight → Equal-Weight
    Morgan Stanley
    11/13/2024$40.00 → $60.00Buy → Hold
    Canaccord Genuity
    11/8/2024$19.00 → $41.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $DOCS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Doximity upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Doximity from Neutral to Overweight and set a new price target of $78.00 from $31.00 previously

      2/7/25 9:03:46 AM ET
      $DOCS
      EDP Services
      Technology
    • Doximity upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Doximity from Market Perform to Outperform and set a new price target of $90.00 from $60.00 previously

      2/7/25 6:59:36 AM ET
      $DOCS
      EDP Services
      Technology
    • Stephens initiated coverage on Doximity with a new price target

      Stephens initiated coverage of Doximity with a rating of Equal-Weight and set a new price target of $55.00

      12/20/24 7:32:05 AM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Doximity Inc.

      SC 13G/A - Doximity, Inc. (0001516513) (Subject)

      11/14/24 5:22:01 PM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form SC 13G filed by Doximity Inc.

      SC 13G - Doximity, Inc. (0001516513) (Subject)

      11/14/24 11:42:53 AM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form SC 13G filed by Doximity Inc.

      SC 13G - Doximity, Inc. (0001516513) (Subject)

      11/12/24 9:55:17 AM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members

      4/24/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025, at 10:25 a.m. Eastern Time/7:25 a.m. Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and rese

      2/13/25 4:29:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

      Earns A-level ratings in all categories Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named 2025 Best in KLAS in the Video Conferencing Platforms segment. This is the fourth consecutive year that Doximity has earned the top position. In addition to securing the #1 spot, Doximity received A-level ratings in all categories, including operations, product, relationship, value, culture, and loyalty. These ratings, which are based on live interviews with over 80 health system leaders and their staff, reinforce Doximity's leadership in delivering a reliable, easy-to-use virtual care platform. "We're hono

      2/6/25 4:02:00 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Leadership Updates

    Live Leadership Updates

    See more

    $DOCS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $DOCS
    SEC Filings

    See more
    • Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

      With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

      9/26/24 6:05:00 AM ET
      $DOCS
      $RELY
      $LVGO
      EDP Services
      Technology
      Business Services
      Consumer Discretionary
    • Doximity Appoints Phoebe Yang to Its Board of Directors

      Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one

      8/4/22 4:02:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Director Wampler Kira Scherer converted options into 2,000 shares and sold $113,853 worth of shares (2,000 units at $56.93) (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      5/2/25 4:19:42 PM ET
      $DOCS
      EDP Services
      Technology
    • Chief Financial Officer Bryson Anna converted options into 95,000 shares and sold $5,575,235 worth of shares (95,000 units at $58.69) (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      5/2/25 4:19:07 PM ET
      $DOCS
      EDP Services
      Technology
    • Chief Financial Officer Bryson Anna converted options into 32,900 shares, increasing direct ownership by 10% to 357,165 units (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      4/22/25 4:14:03 PM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form 144 filed by Doximity Inc.

      144 - Doximity, Inc. (0001516513) (Subject)

      5/2/25 4:06:18 PM ET
      $DOCS
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

      SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

      3/7/25 10:01:30 AM ET
      $DOCS
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.

      SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)

      2/13/25 4:01:03 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    Financials

    Live finance-specific insights

    See more
    • Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members

      4/24/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity Announces Fiscal 2025 Third Quarter Financial Results

      Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024. "We're proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers." Fiscal 2025 Third Quarter Financial Highlights All com

      2/6/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu

      1/16/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology